Serum Uric Acid, Inflammation, and Nondipping Circadian Pattern in Essential Hypertension

Journal of Clinical Hypertension

Volumn 15, Issue 1, 2013, Pages 7-13

  Turak, Osman ^a   Özcan, Firat ^a   Tok, Derya ^a   Işleyen, Ahmet ^a   Sökmen, Erdoǧan ^a   Taşoǧlu, Irfan ^a   Aydoǧdu, Sinan ^a   Sen, Nihat ^b   Mcfann, Kim ^c   Johnson, Richard J ^c   Kanbay, Mehmet ^d  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d Radiology Department   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; URIC ACID;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MEASUREMENT; CIRCADIAN RHYTHM; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD PRESSURE MONITORING, AMBULATORY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; LOGISTIC MODELS; MALE; MIDDLE AGED; URIC ACID;

EID: 84871874055     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12026     Document Type: Article

References (51)

1. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;275:1571-1576.
2. Ogedegbe G, Pickering T. Principles and techniques of blood pressure measurement. Cardiol Clin. 2010;28:571-586.
3. Kanbay M, Turkmen K, Ecder T, Covic A. Ambulatory blood pressure monitoring: from old concepts to novel insights. Int Urol Nephrol. 2012;44:173-182.
4. Verdecchia P, Porcellati C, Schillaci G, et al.Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801.
5. de la Sierra A, Redon J, Banegas JR, et al.Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009;53:466-472.
6. Kahn HA, Medalie JH, Neufeld HN, et al.The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J. 1972;84:171-182.
7. Alper AB Jr, Chen W, Yau L, et al.Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension. 2005;45:34-38.
8. Dyer AR, Liu K, Walsh M, et al.Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens. 1999;13:13-21.
9. Grayson PC, Kim SY, Lavalley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011;63:102-110.
10. Hunt SC, Stephenson SH, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension. 1991;17(6 Pt 2):969-976.
11. Jossa F, Farinaro E, Panico S, et al.Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens. 1994;8:677-681.
12. Masuo K, Kawaguchi H, Mikami H, et al.Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003;42:474-480.
13. Nagahama K, Inoue T, Iseki K, et al.Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res. 2004;27:835-841.
14. Nakanishi N, Okamoto M, Yoshida H, et al.Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol. 2003;18:523-530.
15. Shankar A, Klein R, Klein BE, Nieto FJ. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens. 2006;20:937-945.
16. Sundstrom J, Sullivan L, D'Agostino RB, et al.Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005;45:28-33.
17. Taniguchi Y, Hayashi T, Tsumura K, et al.Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens. 2001;19:1209-1215.
18. Cannon PJ, Stason WB, Demartini FE, et al.Hyperuricemia in primary and renal hypertension. N Engl J Med. 1966;275:457-464.
19. Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens. 2007;25:1583-1589.
20. Bellomo G, Venanzi S, Saronio P, et al.Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension. 2011;58:704-708.
21. Redman CW, Beilin LJ, Bonnar J, Wilkinson RH. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet. 1976;1:1370-1373.
22. Loeffler LF, Navas-Acien A, Brady TM, et al.Uric acid level and elevated blood pressure in US Adolescents: National Health and Nutrition Examination Survey, 1999-2006. Hypertension. 2012;59:811-817.
23. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 2003;42:247-252.
24. Sanchez-Lozada LG, Soto V, Tapia E, et al.Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol. 2008;295:F1134-F1141.
25. Sanchez-Lozada LG, Tapia E, Lopez-Molina R, et al.Effects of acute and chronic L-arginine treatment in experimental hyperuricemia. Am J Physiol. 2007;292:F1238-F1244.
26. Mazzali M, Hughes J, Kim YG, et al.Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38:1101-1106.
27. Mazzali M, Kanellis J, Han L, et al.Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol. 2002;282:F991-F997.
28. Watanabe S, Kang DH, Feng L, et al.Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension. 2002;40:355-360.
29. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem. 1991;266:8604-8608.
30. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16:3553-3562.
31. Kanbay M, Ozkara A, Selcoki Y, et al.Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol. 2007;39:1227-1233.
32. Kanbay M, Huddam B, Azak A, et al.A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011;6:1887-1894.
33. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on the blood pressure of adolescents with newly diagnosed essential hypertension. JAMA. 2008;300:922-930.
34. Chobanian AV, Bakris GL, Black HR, et al.The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
35. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009.
36. Mazzali M, Kanbay M, Segal MS, et al.Uric acid and hypertension: cause or effect?Curr Rheumatol Rep. 2010;12:108-117.
37. Mohamed FA. The etiology of Bright's disease and the prealbuminuric state. Med Chir Trans. 1874;39:197-228.
38. Schmidt MI, Watson RL, Duncan BB, et al.Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism. 1996;45:699-706.
39. Johnson RJ, Kang DH, Feig D, et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?Hypertension. 2003;41:1183-1190.
40. Verdecchia P, Schillaci G, Reboldi G, et al.Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension. 2000;36:1072-1078.
41. Kario K, Pickering TG, Matsuo T, et al.Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852-857.
42. Mann S, Altman DG, Raftery EB, Bannister R. Circadian variation of blood pressure in autonomic failure. Circulation. 1983;68:477-483.
43. Sherwood A, Routledge FS, Wohlgemuth WK, et al.Blood pressure dipping: ethnicity, sleep quality, and sympathetic nervous system activity. Am J Hypertens. 2011;24:982-988.
44. Kaya MG, Yarlioglues M, Gunebakmaz O, et al.Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis. 2010;209:278-282.
45. Ermis N, Yagmur J, Acikgoz N, et al.Serum gamma-glutamyl transferase (GGT) levels and inflammatory activity in patients with non-dipper hypertension. Clin Exp Hypertens. 2012;34:311-315.
46. Kanellis J, Watanabe S, Li JH, et al.Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41:1287-1293.
47. Lyngdoh T, Marques-Vidal P, Paccaud F, et al.Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS ONE. 2011;6:e19901.
48. Coutinho Tde A, Turner ST, Peyser PA, et al.Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens. 2007;20:83-89.
49. Wasilewska A. Is duration of breastfeeding in infancy associated with serum uric acid levels and markers of low-grade inflammation in children. Acta Paediatr. 2012;March 27.
50. Vekic J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, et al.High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles. Atherosclerosis. 2009;203:236-242.
51. Meisinger C, Koenig W, Baumert J, Doring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol. 2008;28:1186-1192.